Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04170894 · ClinicalTrials.gov registry record · NA

Radiofrequency Ablation of Atrial Fibrillation Under Apnea

A NA study, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
128
Enrollment target

NCT04170894 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 128 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04170894, a NA study, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
128 participants
Enrollment target

Study Summary

This study seeks to assess the effect of apnea (breath hold) during atrial fibrillation (AF) ablation by having all ablations performed under apnea. By prospectively studying the effects of apnea on AF ablation, the investigators wish to demonstrate its feasibility, safety and impact on patient outcomes. This is a prospective study that includes both an apnea arm and a control arm. The subjects who consent to the apnea arm will undergo an atrial fibrillation ablation with periods of apnea. The subjects who consent to the control arm will agree to have their data from their standard of care atrial fibrillation be collected for comparison.

Interventions

  • OTHER Periods of Apnea
  • OTHER Control Arm - No Periods of Apnea

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2020-10-08
Est. Completion 2023-08-30
Phase NA

What the Registry Record Tells You About NCT04170894

The ClinicalTrials.gov registry entry for NCT04170894 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Periods of Apnea is the first listed.

NCT04170894 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04170894 about?

NCT04170894 is a clinical study titled "Radiofrequency Ablation of Atrial Fibrillation Under Apnea". This study seeks to assess the effect of apnea (breath hold) during atrial fibrillation (AF) ablation by having all ablations performed under apnea. By prospectively studying the effects of apnea on AF ablation, the investigators wish to demonstrate its feasibility, safety and impact on patient outc...

What is the current status of trial NCT04170894?

This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2020-10-08. Estimated completion is 2023-08-30.

What interventions are being tested in trial NCT04170894?

The interventions under investigation include: Periods of Apnea (OTHER), Control Arm - No Periods of Apnea (OTHER).

Who is sponsoring clinical trial NCT04170894?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.